SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 133 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 3.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $151,658,000 | +23.7% | 1,554,979 | +17.7% | 0.01% | +11.1% |
| Q4 2014 | $122,569,000 | +37.7% | 1,320,921 | +2.1% | 0.01% | +28.6% |
| Q3 2014 | $89,002,000 | -31.5% | 1,294,021 | +4.3% | 0.01% | -30.0% |
| Q2 2014 | $129,992,000 | +47.3% | 1,240,381 | +16.6% | 0.01% | +42.9% |
| Q1 2014 | $88,251,000 | +42.7% | 1,063,652 | +11.3% | 0.01% | +40.0% |
| Q4 2013 | $61,849,000 | +12.6% | 955,628 | +10.1% | 0.01% | 0.0% |
| Q3 2013 | $54,927,000 | +99.3% | 867,605 | +32.2% | 0.01% | +66.7% |
| Q2 2013 | $27,562,000 | – | 656,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $989,182,000 | 10.10% |
| BB BIOTECH AG | 1,130,476 | $104,897,000 | 3.40% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 80,000 | $7,423,000 | 3.31% |
| Opus Point Partners Management, LLC | 20,002 | $1,856,000 | 1.84% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,847,094 | $356,972,000 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 363,884 | $33,765,000 | 1.52% |
| Cormorant Asset Management, LP | 100,000 | $9,279,000 | 1.43% |
| Tekla Capital Management LLC | 223,020 | $20,694,000 | 0.97% |
| Lamond Capital Partners LLC | 15,390 | $1,428,000 | 0.94% |
| Squarepoint Ops LLC | 6,700 | $622,000 | 0.60% |